INTEGRATED BIOPHARMA INC Quarterly Nonoperating Income (Expense) in USD from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Integrated Biopharma Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from Q4 2010 to Q2 2024.
  • Integrated Biopharma Inc Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $12K, a 200% increase year-over-year.
  • Integrated Biopharma Inc Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $17K.
  • Integrated Biopharma Inc annual Nonoperating Income (Expense) for 2024 was $17K.
  • Integrated Biopharma Inc annual Nonoperating Income (Expense) for 2023 was -$20K, a 86.5% increase from 2022.
  • Integrated Biopharma Inc annual Nonoperating Income (Expense) for 2022 was -$148K, a 110% decline from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $17K $12K +$8K +200% Apr 1, 2024 Jun 30, 2024 10-K 2024-09-20
Q1 2024 $9K -$3K -$5K -250% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $14K $0 +$12K Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-12
Q3 2023 $2K $8K +$22K Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$20K $4K +$35K Apr 1, 2023 Jun 30, 2023 10-K 2024-09-20
Q1 2023 -$55K $2K +$34K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$89K -$12K +$27K +69.2% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-12
Q3 2022 -$116K -$14K +$32K +69.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$148K -$31K -$1.66M -102% Apr 1, 2022 Jun 30, 2022 10-K 2023-09-15
Q1 2022 $1.52M -$32K -$19K -146% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $1.53M -$39K +$76K +66.1% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-10
Q3 2021 $1.46M -$46K -$5K -12.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $1.46M $1.63M +$1.59M +3372% Apr 1, 2021 Jun 30, 2021 10-K 2022-09-13
Q1 2021 -$122K -$13K -$56K -130% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$66K -$115K +$19K +14.2% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-10
Q3 2020 -$85K -$41K +$86K +67.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$171K $47K +$164K Apr 1, 2020 Jun 30, 2020 10-K 2021-09-02
Q1 2020 -$335K $43K +$214K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$549K -$134K +$49K +26.8% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-12
Q3 2019 -$598K -$127K +$64K +33.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$662K -$117K -$239K -196% Apr 1, 2019 Jun 30, 2019 10-K 2020-09-23
Q1 2019 -$423K -$171K -$2K -1.18% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 -$421K -$183K +$25K +12% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-12
Q3 2018 -$446K -$191K +$243K +56% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$689K $122K Apr 1, 2018 Jun 30, 2018 10-K 2019-08-29
Q1 2018 -$169K -$46K -37.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$208K +$368K +63.9% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-13
Q3 2017 -$434K +$150K +25.7% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q1 2017 -$123K +$240K +66.1% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 -$576K -$365K -173% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-09
Q3 2016 -$584K -$368K -170% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q1 2016 -$958K -$363K -$269K -286% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$689K -$211K -$426K -198% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-10
Q3 2015 -$263K -$216K -$199K -1171% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$64K -$168K +$257K +60.5% Apr 1, 2015 Jun 30, 2015 10-K 2016-09-02
Q1 2015 -$321K -$94K +$133K +58.6% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 -$454K $215K +$376K Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-19
Q3 2014 -$830K -$17K +$302K +94.7% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 -$1.13M -$425K -$653K -286% Apr 1, 2014 Jun 30, 2014 10-K 2015-09-04
Q1 2014 -$479K -$227K +$465K +67.2% Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-14
Q4 2013 -$944K -$161K -$958K -120% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-17
Q3 2013 $14K -$319K +$1.02M +76.2% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 -$1.01M $228K +$608K Apr 1, 2013 Jun 30, 2013 10-K 2014-09-08
Q1 2013 -$1.61M -$692K -$401K -138% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q4 2012 -$1.21M $797K +$2.08M Oct 1, 2012 Dec 31, 2012 10-Q/A 2014-02-13
Q3 2012 -$3.29M -$1.34M -$1.09M -442% Jul 1, 2012 Sep 30, 2012 10-Q 2012-11-19
Q2 2012 -$2.2M -$380K Apr 1, 2012 Jun 30, 2012 10-K 2012-10-15
Q1 2012 -$291K +$222K +43.3% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$1.28M -$763K -148% Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-19
Q3 2011 -$247K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-19
Q1 2011 -$513K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-21
Q4 2010 -$515K Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.